Showing results (7281-7290 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|August 28, 2012
Hsp70 protein complexes as drug targetsVictoria A Assimon, Anne T Gillies, Jennifer N Rauch, et al.Current Pharmaceutical Design|September 29, 2012
The proteasome in health and diseaseElzbieta Jankowska, Julia Stoj, Przemyslaw Karpowicz, et al.Current Pharmaceutical Design|September 29, 2012
Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseasesAina He, Guo-Ping ShiCurrent Pharmaceutical Design|September 29, 2012
Selective inhibitors of human neutrophil proteinase 3Brice Korkmaz, Christine Kellenberger, Marie-Claude Viaud-Massuard, et al.Current Pharmaceutical Design|September 29, 2012
Future of protease activity assaysMagdalena Wysocka, Adam LesnerCurrent Pharmaceutical Design|September 29, 2012
HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytologySveinung Wergeland Sørbye, Silje Fismen, Tore Jarl Gutteberg, et al.Current Pharmaceutical Design|September 29, 2012
The problem of false-positive human papillomavirus DNA tests in cervical screeningMatejka Rebolj, Igor Pribac, Maria Eiholm Frederiksen, et al.Current Pharmaceutical Design|September 29, 2012
The mRNA-HPV test utilization in the follow up of HPV related cervical lesionsAndrea Tinelli, Marcello Guido, Antonella Zizza, et al.Current Pharmaceutical Design|September 29, 2012
Computational approaches for ligand discovery and design in class-A G protein- coupled receptorsDavid Rodríguez, Hugo Gutiérrez-de-TeránCurrent Pharmaceutical Design|September 29, 2012
Modeling of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one derivatives by several conformational searching tools and molecular dockingMohammad Goodarzi, Alina Bora, Ana Borota, et al.Pageof 1,009